arv-471
Showing 1 - 10 of 10
Healthy Trial (ARV-471, Dabigatran etexilate)
Not yet recruiting
- Healthy
- ARV-471
- Dabigatran etexilate
- (no location specified)
Dec 21, 2022
Breast Cancer Trial (ARV-471, Anastrozole, Surgical resection of breast tumor)
Recruiting
- Breast Cancer
- ARV-471
- +2 more
-
Saint Louis, MissouriClinical Trial Site
Jan 26, 2023
Breast Cancer Trial in Shanghai (ARV-471)
Not yet recruiting
- Breast Cancer
- ARV-471
-
Shanghai, ChinaCancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2023
Healthy Trial in New Haven (ARV-471, Rosuvastatin)
Recruiting
- Healthy
- ARV-471
- Rosuvastatin
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Dec 29, 2022
Breast Tumors Trial in Nagoya, Kashiwa, Chuo-ku (ARV-471)
Not yet recruiting
- Breast Neoplasms
- ARV-471
-
Nagoya, Aichi, Japan
- +2 more
Aug 12, 2022
Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCEĀ®))
Recruiting
- Breast Cancer
- ARV-471
- ARV-471 in combination with palbociclib (IBRANCEĀ®)
-
Palo Alto, California
- +16 more
Jan 30, 2023